Assessment of β-Lactamase Inhibitor Potential of Medicinal Plant Extracts against Antibiotic-resistant Staphylococcus aureus
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study was designed to assess the possibility of using medicinal plant extracts as β-lactamase inhibitors tocontrol antibiotic-resistant Staphylococcus aureus. The susceptibilities of S. aureus ATCC 15564 (SAWT), ciprofloxacininduced S. aureus ATCC 15564 (SACIP), oxacillin-induced S. aureus ATCC 15564 (SAOXA), and clinically-isolated S. aureus CCARM 3008 (SACLI) to ampicillin were determined in the absence and presence of medicinal plant extracts,including Cleyera japonica (CJ), Carpinus laxiflora (CL), Euphorbia helioscopia (EH), Euscaphis japonica (EJ),Oenothera erythrosepala (OE), and Rosa multiflora (RM). The phenotypic change in the clear inhibition zones aroundampicillin disc was observed for SAWT, SACIP, and SAOXA, indicating the production of ampicillinase. Compared to thecontrols, the MICs of ampicillin against SAWT, SACIP, and SAOXA were decreased from 4 to 0.5 ㎍/mL in the presence of CL,16 to 4 ㎍/mL in the presence of RM, and 32 to 2 ㎍/mL in the presence of CL, EH, and RM, respectively. The medicinalplant extracts, OE, EJ, and CL, effectively inhibited the β-lactamase activities of SAWT (78%), SACIP (57%), and SAOXA(76%) when compared to the control. This results suggest that the medicinal plant extracts can be used as BLIs to control theantibiotic-resistant S. aureus.
Abstract
This study was designed to assess the possibility of using medicinal plant extracts as β-lactamase inhibitors tocontrol antibiotic-resistant Staphylococcus aureus. The susceptibilities of S. aureus ATCC 15564 (SAWT), ciprofloxacininduced S. aureus ATCC 15564 (SACIP), oxacillin-induced S. aureus ATCC 15564 (SAOXA), and clinically-isolated S. aureus CCARM 3008 (SACLI) to ampicillin were determined in the absence and presence of medicinal plant extracts,including Cleyera japonica (CJ), Carpinus laxiflora (CL), Euphorbia helioscopia (EH), Euscaphis japonica (EJ),Oenothera erythrosepala (OE), and Rosa multiflora (RM). The phenotypic change in the clear inhibition zones aroundampicillin disc was observed for SAWT, SACIP, and SAOXA, indicating the production of ampicillinase. Compared to thecontrols, the MICs of ampicillin against SAWT, SACIP, and SAOXA were decreased from 4 to 0.5 ㎍/mL in the presence of CL,16 to 4 ㎍/mL in the presence of RM, and 32 to 2 ㎍/mL in the presence of CL, EH, and RM, respectively. The medicinalplant extracts, OE, EJ, and CL, effectively inhibited the β-lactamase activities of SAWT (78%), SACIP (57%), and SAOXA(76%) when compared to the control. This results suggest that the medicinal plant extracts can be used as BLIs to control theantibiotic-resistant S. aureus.
참고문헌 (36)
- Akova, M, "Sulbactam-containing b-lactamase inhibitor combinations", Clin. Microbiol. Infect, 14, pp.185~188 (2008)
- Amjad, A., "Modified Hodge test : A simple and effective test for detection of carbapenemase production", Iran J Microbiol, 3, pp.189~193 (2011)
- Anderson, K. F., "Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae", J. Clin. Microbiol, 45, pp.2723~2725 (2007)
- Aparna, V., "Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using In silico high-throughput virtual screening and in vitro validation", PLoS One, 9, pp.e101840~ (2014)
- Barry, G. H., "Revised Ambler classification of b-lactamases", J. Antimicrob. Chemother, 55, pp.1050~1051 (2005)
- Bauernfeind, A, "Classification of β-lactamases", Rev. Infect. Dis., 8, pp.S470~S481 (1986)
- Boussoualim, N., "Kinetic study of different flavonoids as inhibitors of beta-lactamase enzyme", Afr. J. Biochem. Res., 5, pp.321~327 (2011)
- Bush, K., "β-Lactams and β-lactamase inhibitors: An overview", Cold Spring Harbor Perspect. Med, 6, pp.a025247~ (2016)
- Catteau, L., "Synergy between ursolic and oleanolic acids from Vitellaria paradoxa leaf extract and β-lactams against methicillin-resistant Staphylococcus aureus: In vitro and in vivo activity and underlying mechanisms", Molecules, 22, pp.2245~ (2017)
- Cendrowski, A., "Antibacterial and antioxidant activity of extracts from rose fruits (Rosa rugosa)", Molecules, 25, pp.E1365~ (2020)
- Cheng, M. P., "Beta-lactam", beta-lactamase inhibitor therapy for potential AmpC-producing organisms: A systematic review and meta-analysis, 2019, pp.6, ofz248~
- CLSI, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically", Approved Standard M07-A10, ~ (2015)
- Elizaquível, P., "Evaluation of Zataria multiflora Boiss. essential oil activity against Escherichia coli O157:H7, Salmonella enterica and Listeria monocytogenes by propidium monoazide quantitative PCR in vegetables", Food Cont, 34, pp.770~776 (2013)
- Eumkeb, G., "Reversing β-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime", Phytomedicine, 18, pp.40~45 (2010)
- Eumkeb, G., "Synergistic activity and mode of action of flavonoids isolated from smaller galangal and amoxicillin combinations against amoxicillin‐resistant Escherichia coli", J. Appl. Microbiol, 112, pp.55~64 (2012)
- Féria, C., "Patterns and mechanisms of resistance to b-lactams and b-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal", J. Antimicrob. Chemother, 49, pp.77~85 (2002)
- Fuda, C. C. S., "β-Lactam resistance in Staphylococcus aureus: The adaptive resistance of a plastic genome", Cell. Mol. Life Sci., 62, pp.2617~ (2005)
- Hanson, N. D., "Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae", Curr. Pharmaceut. Design, 5, pp.881~894 (1999)
- Hou, W. C., "Free radicalscavenging activity of Taiwanese native plants", Phytomedicine, 10, pp.170~175 (2003)
- Lamers, R. P., "The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria", PLoS One, 8, pp.e60666~ (2013)
- 이승현, "Inhibitory Effects of Pine Cone (Pinus densiflora) on Melanogenesis in B16F10 Melanoma Cells", 한국자원식물학회지, 32(4), pp.275~281 (2019), 한국자원식물학회
- Liu, X., "Occurrence of OXA-48 carbapenemase and other b-lactamase genes in ESBL-producing multidrug resistant Escherichia coli from dogs and cats in the United States, 2009-2013", Front. Microbiol, 7, pp.1057~ (2016)
- Llarrull, L. I., "Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new β-lactams that meet the challenge", Antimicrob. Agent Chemother, 53, pp.4051~4063 (2009)
- Manchanda, V., "Occurrence and detection of AmpC b-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India", J. Antimicrob. Chemother, 51, pp.415~418 (2003)
- Matsumoto, Y., "Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels", PLoS One, 6, pp.e18547~ (2011)
- Michéa-Hamzehpour, M., "In vitro stepwise selection of resistance to quinolones, β-lactams and amikacin in nosocomial gram-negative bacilli", Infection, 22, pp.S105~S110 (1994)
- Payne, D. J., "Rapid identification of metallo- and serine b-lactamases", Antimicrob. Agent. Chemother., 38, pp.991~996 (1994)
- Rubens, D. M., "Anti Staphylococcus aureus activity of the aqueous extract and hexanic fraction of Thonningia sanguinea (Cote ivoire)", Int. J. Pharmaco. Phytochem. Res., 7, pp.301~306 (2015)
- Rumbo, C., "Contribution of efflux pumps, porins, and b-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii", Antimicrob. Agent. Chemother, 57, pp.5247~5257 (2013)
- Sibanda, T., "The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents", Afr. J. Biotechnol, 6, pp.2886~2896 (2007)
- Sood, S, "Comparative evaluation of the in-vitro activity of six β-lactam", β-lactamase inhibitor combinations against Gram negative Bacilli, 2013, pp.7, 224~228
- Stapleton, P., "Modulation of b-lactam resistance in Staphylococcus aureus by catechins and gallates", Int. J. Antimicrob. Agents, 23, pp.462~467 (2004)
- Sun, S., "Resistance to β-lactam antibiotics conferred by point mutations in penicillinbinding proteins PBP3, PBP4 and PBP6 in Salmonella enterica", PLoS One, 9, pp.e97202~ (2014)
- Venkatesan, A. M., "Novel imidazole substituted 6-methylidene-penems as broad-spectrum β-lactamase inhibitors", Bioorg. Med. Chem., 12, pp.5807~5817 (2004)
- Zabawa, T. P., "Treatment of Gram-negative bacterial infections by potentiation of antibiotics", Curr. Opin. Microbiol, 33, pp.7~12 (2016)
- Zhao, W. -H., "Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus", Antimicrob. Agent Chemother, 46, pp.2266~2268 (2002)
